https://www.selleckchem.com/pr....oducts/deferoxamine-
Background Cancer remains the number one cause of disease-related mortality in children, and despite advances in the molecular understanding of leukemia and targeted therapies, refractory leukemia remains a leading cause of death. It therefore is essential to further define features, e.g., FLT3 alterations and KMT2A rearrangements, associated with inferior survival early to augment or alter therapeutic strategies to improve outcomes. Methods To gain insights into the genetic drivers predictive of aggressive clinical behavi
Мне нравится
Комментарий
Перепост
